Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) EPS (Weighted Average and Diluted): 2018-2025

Historic EPS (Weighted Average and Diluted) for Organogenesis Holdings (ORGO) over the last 6 years, with Sep 2025 value amounting to $0.11.

  • Organogenesis Holdings' EPS (Weighted Average and Diluted) rose 22.22% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.12, marking a year-over-year decrease of 86.69%. This contributed to the annual value of -$0.01 for FY2024, which is 125.00% down from last year.
  • Per Organogenesis Holdings' latest filing, its EPS (Weighted Average and Diluted) stood at $0.11 for Q3 2025, which was up 210.00% from -$0.10 recorded in Q2 2025.
  • Organogenesis Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.38 during Q4 2021, with a 5-year trough of -$0.17 in Q1 2025.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.01, with a median of -$0.00 in 2023.
  • Per our database at Business Quant, Organogenesis Holdings' EPS (Weighted Average and Diluted) skyrocketed by 1,133.07% in 2023 and then slumped by 750.00% in 2025.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' EPS (Weighted Average and Diluted) stood at $0.38 in 2021, then crashed by 84.21% to $0.06 in 2022, then crashed by 107.13% to -$0.00 in 2023, then soared by 1,034.84% to $0.04 in 2024, then climbed by 22.22% to $0.11 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.11 in Q3 2025, compared to -$0.10 in Q2 2025 and -$0.17 in Q1 2025.